相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232
Michael J. Borowitz et al.
BLOOD (2015)
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab
Anamarija M. Perry et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations
Mette O. Pedersen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
Sietse M. Aukema et al.
HAEMATOLOGICA (2014)
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
Heike Horn et al.
BLOOD (2013)
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
Shimin Hu et al.
BLOOD (2013)
High Levels of Nuclear MYC Protein Predict the Presence of MYC Rearrangement in Diffuse Large B-cell Lymphoma
Tina Marie Green et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience
Mette O. Pedersen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Tina Marie Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Nathalie A. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18) (q32;q21): an aggressive disease with heterogeneous histology, germina center B-cell immunophenotype and poor outcome
Shaoying Li et al.
MODERN PATHOLOGY (2012)
MYC and Aggressive B-cell Lymphomas
Graham W. Slack et al.
ADVANCES IN ANATOMIC PATHOLOGY (2011)
De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13
Shivakumar Subramaniyam et al.
LEUKEMIA & LYMPHOMA (2011)
Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
Sharon Barrans et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial
Anthony V. Moorman et al.
LANCET ONCOLOGY (2010)
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
Nathalie A. Johnson et al.
BLOOD (2009)
Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells
Masayoshi Kobune et al.
CANCER SCIENCE (2009)
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations
Naoto Tomita et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment
E. C. Obermann et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type
S. O. Yoon et al.
HISTOPATHOLOGY (2008)
The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement
Steven Le Gouill et al.
HAEMATOLOGICA (2007)
Characterization of early stages of human B cell development by gene expression profiling
Marit E. Hystad et al.
JOURNAL OF IMMUNOLOGY (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
Anthony V. Moorman et al.
BLOOD (2007)
Translocation (14;18)(q32;q21) in acute lymphoblastic leukemia: a study of 12 cases and review of the literature
Pina D'Achille et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis
A Kanungo et al.
MODERN PATHOLOGY (2006)
De novo acute B cell leukemia/lymphoma with t(14;18)
A Stamatoullas et al.
LEUKEMIA (2000)